1734-1922

Archives of Medical Science

Termedia Sp. z.o.o.

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add license metadata to 1721 records

License metadata tells indexers and readers how each article may be reused.

High impact1721 DOIs
2

Deposit reference lists for 1547 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact1547 DOIs
3

Attach ORCID iDs across 1443 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1443 DOIs

DOIs for this ISSN

Showing the top 5 of 1738 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Metabolic syndrome – a new definition and management guideli… (10.5114/aoms/152921)
Abstract References ORCID License
220.68 160
2 Effects of free and nanoparticulate curcumin on chemically i… (10.5114/aoms.2020.93739)
References ORCID License
136.47 65
3 Effect of atorvastatin on delirium status of patients in the… (10.5114/aoms.2019.89330)
References ORCID License
131.11 55
4 Quality of life, anxiety and depressive disorders in patient… (10.5114/aoms.2020.101359)
References ORCID License
130.53 54
5 Berberine induces apoptosis and arrests the cell cycle in mu… (10.5114/aoms/132969)
References ORCID License
126.76 48
6 National and regional trends in the prevalence of polycystic… (10.5114/aoms.2019.87112)
References ORCID License
125.41 46
7 Global epidemiological characteristics of uterine fibroids (10.5114/aoms/171786)
References ORCID License
125.41 46
8 PCSK9 immunization using nanoliposomes: preventive efficacy… (10.5114/aoms/133885)
References ORCID License
124.71 45
9 Statins as anti-pyroptotic agents (10.5114/aoms/141155)
References ORCID License
123.26 43
10 Comparison of rituximab, cyclophosphamide, and tacrolimus as… (10.5114/aoms/145587)
Abstract References ORCID License
123.04 16
11 Protective mechanism of kaempferol against Aβ25-35-mediated… (10.5114/aoms.2020.98199)
References ORCID License
116.72 35
12 Adipokine signatures of subcutaneous and visceral abdominal… (10.5114/aoms/92118)
References ORCID License
116.72 35
13 Menopause and women’s cardiovascular health: is it really an… (10.5114/aoms/157308)
References License
116.01 208
14 On the present and future role of Lp-PLA2 in atherosclerosis… (10.5114/aoms.2020.98195)
References ORCID License
114.86 33
15 Role of the interleukin-17 pathway in the pathogenesis of at… (10.5114/aoms/130392)
Abstract References ORCID License
114.61 13
16 Prognostic value of the PIK3CA, AKT, and PTEN mutations in o… (10.5114/aoms.2020.100780)
References ORCID License
112.89 31
17 Atrial fibrillation risk factors in patients with ischemic s… (10.5114/aoms.2019.84212)
References ORCID License
109.68 28
18 Salidroside regulates imbalance of Th17/Treg and promotes i… (10.5114/aoms.2019.85349)
References ORCID License
108.54 27
19 Medium- to long-term clinical and functional outcomes of iso… (10.5114/aoms.2020.97714)
References ORCID License
108.54 27
20 Ibrutinib attenuated DSS-induced ulcerative colitis, oxidati… (10.5114/aoms/146792)
Abstract References ORCID License
107.92 11
21 Genetic syndromes with vascular malformations – update on mo… (10.5114/aoms.2020.93260)
References ORCID License
107.35 26
22 Quantification of long non-coding RNAs using qRT-PCR: compar… (10.5114/aoms.2019.82639)
References ORCID License
104.85 24
23 Decreased interleukin-35 levels and CD4+EBI3+ T cells in pat… (10.5114/aoms.2020.101510)
Abstract References ORCID License
104.14 10
24 Postmarketing nutrivigilance safety profile: a line of diet… (10.5114/aoms/133716)
References ORCID License
103.52 23
25 The role of statins in lung cancer (10.5114/aoms/123225)
References ORCID License
102.13 22
26 PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and ther… (10.5114/aoms/141941)
References License
102.07 109
27 Antioxidative activity of probiotics (10.5114/aoms.2019.89894)
ORCID License
101.06 104
28 Sarcopenia is associated with increased severe postoperative… (10.5114/aoms.2019.88621)
References ORCID License
100.68 21
29 CNTN-1 promotes docetaxel resistance and epithelial-to-mesen… (10.5114/aoms.2020.92939)
References ORCID License
100.68 21
30 Mesenchymal soluble factors confer imatinib drug resistance… (10.5114/aoms.2020.101042)
Abstract References ORCID License
100.00 9
31 Prophylactic administration of recombinant human thrombopoie… (10.5114/aoms/141134)
Abstract References ORCID License
100.00 9
32 Safety and efficacy of naltrexone for weight loss in adult p… (10.5114/aoms.2020.96908)
References ORCID License
97.58 19
33 The prevalence, disability-adjusted life years, and mortalit… (10.5114/aoms/169477)
References ORCID License
97.58 19
34 The association between frailty and osteoarthritis based on… (10.5114/aoms/171270)
References ORCID License
97.58 19
35 Epidemiology of hypertensive heart disease in Poland: findin… (10.5114/aoms.2019.85222)
References ORCID License
95.91 18
36 Edaravone attenuates neuronal apoptosis in hippocampus of ra… (10.5114/aoms.2019.89849)
References ORCID License
95.91 18
37 Cancer screening coverage in Poland – from bad to better to… (10.5114/aoms/134239)
Abstract References ORCID License
95.42 8
38 Soluble P-selectin level in patients with cancer-associated… (10.5114/aoms/159039)
Abstract References ORCID License
95.42 8
39 Naringin attenuates high glucose-induced injuries and inflam… (10.5114/aoms.2019.84854)
References ORCID License
94.15 17
40 The anterior cingulate cortex projection to the dorsomedial… (10.5114/aoms.2019.85202)
References ORCID License
94.15 17
41 Zinc finger of the cerebellum 5 promotes colorectal cancer c… (10.5114/aoms.2019.89677)
References ORCID License
94.15 17
42 MiR-338-3p improved lung adenocarcinoma by AKAP12 suppressio… (10.5114/aoms.2019.90913)
References ORCID License
94.15 17
43 How to balance the treatment of stress urinary incontinence… (10.5114/aoms.2020.100139)
References ORCID License
94.15 17
44 Reduction of lymphocyte count at early stage elevates severi… (10.5114/aoms.2020.99006)
References ORCID License
92.28 16
45 Improved COVID-19 ICU admission and mortality outcomes follo… (10.5114/aoms/132950)
ORCID License
90.65 64
46 Predictors of disability in patients with chronic low back p… (10.5114/aoms.2020.97057)
References ORCID License
90.31 15
47 Nanoparticles: a breakthrough in COVID-19 prevention, diagno… (10.5114/aoms/142103)
References ORCID License
90.31 15
48 Treatment adherence and effect of concurrent statin intensit… (10.5114/aoms/143476)
References ORCID License
90.31 15
49 Hepatic glycogen storage diseases: pathogenesis, clinical sy… (10.5114/aoms.2019.83063)
References ORCID License
88.21 14
50 Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated… (10.5114/aoms.2019.86609)
References ORCID License
88.21 14